down arrow

Lucy Scientific Discovery, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA54960E1043
USD
0.00
0.00 (0.00%)

Dec 02

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Aytu Biopharma, Inc.
Biofrontera, Inc.
RenovoRx, Inc.
Iterum Therapeutics Plc
Cingulate, Inc.
Eterna Therapeutics, Inc.
VYNE Therapeutics, Inc.
Pasithea Therapeutics Corp.
GT Biopharma, Inc.
Lucy Scientific Discovery, Inc.
RVL Pharmaceuticals Plc
Why is Lucy Scientific Discovery, Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Lucy Scientific Discovery, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Lucy Scientific Discovery, Inc.
-40.0%
-0.01
11056.35%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-87.50%
EBIT Growth (5y)
-171.55%
EBIT to Interest (avg)
-0.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.86%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
0.00
EV to EBIT
-0.08
EV to EBITDA
-0.08
EV to Capital Employed
0.43
EV to Sales
0.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-576.53%
ROE (Latest)
-773.14%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Lucy Scientific Discovery, Inc.
Net Profit
Higher at USD -2.89 MM
than preceding 12 month period ended Dec 2023
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Here's what is not working for Lucy Scientific Discovery, Inc.
Net Profit
At USD -2.89 MM has Grown at -25.43%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Raw Material Cost
Grown by 13,827% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."